Mirion Technologies, Inc. (MIR)
NYSEInformation TechnologyIndustrial - MachinerySnapshot 2026-09-04
$16.93+1.01%
Close 2026-09-04 · 1-day change
NYSEInformation TechnologyIndustrial - MachinerySnapshot 2026-09-04
Intact: The reason to own it still holds.
Mirion grew revenue 27.5% last quarter. It aims for 16-24% revenue growth in 2026. Free cash flow should reach about $165 million in 2026. The company invests in safety tech for growing radiation markets.
Operating income fell from $8.7M to $3.7M last year. Cash from operations dropped nearly $17M. The company cut EPS guidance for 2026. These show weak profit and cash flow trends.
The price is about 12% above our fair value near $14.7. Analysts expect 16% revenue growth. We see risks in profit and cash flow that may pressure results.
Breaks if: Free cash flow falls below $155 million in FY26
Breaks if: Operating income declines further or stays below $3.7M
Breaks if: YoY revenue growth falls below 16% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
MIR represents a speculative growth investment. The company has shown strong recent financial performance but is still loss-making and faces management volatility, which adds uncertainty to its future trajectory.
The current valuation is considered expensive compared to peers, with a premium of 1.09. The market appears to have priced in a justified level of expectations, but there is a gap of -0.28, indicating some skepticism about future performance.
MIR's revenue growth is on track, with management targeting an increase of 22% to 24% for 2026. However, adjusted free cash flow shows mixed progress, which could impact overall financial health in the near term.
The thesis hinges on management's ability to meet revenue and EBITDA targets, as well as external factors like potential Federal Reserve rate cuts and performance from sector peers. Any guidance cuts in future calls could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Focus on increasing revenue growth through strategic initiatives and market expansion.
In the next 1 to 3 years, MIR's performance will depend on execution against its targets and broader market conditions. Not investment advice.